ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph F. Sabik
Thomas W. Rice
Thomas J. Kirby
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabik, J. F.
Right arrow Articles by Adelstein, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabik, J. F.
Right arrow Articles by Adelstein, D. J.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1995;60:896-901
© 1995 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Superficial Esophageal Carcinoma

Joseph F. Sabik, MD, Thomas W. Rice, MD, John R. Goldblum, MD, Anuradha Koka, MD, Thomas J. Kirby, MD, Sharon V. Medendorp, MPH, David J. Adelstein, MD

Departments of Thoracic and Cardiovascular Surgery, Anatomic Pathology, Radiation Oncology, Biostatistics and Epidemiology, and Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio

Background. The detection of superficial esophageal carcinomas by surveillance endoscopy and the downstaging of advanced carcinomas to superficial carcinomas by induction therapy have increased the number of patients with these carcinomas undergoing resection. The natural history of these carcinomas is not well defined.

Methods. To evaluate the results of surgical resection and identify predictors of improved survival, a retrospective review of (1) patients with superficial esophageal carcinoma at presentation (SECP) and (2) patients with advanced carcinomas that were downstaged to no residual carcinoma or superficial esophageal carcinoma after induction therapy (SECD) was conducted.

Results. There were 54 patients with SECP (19 Tis and 35 T1). Survival was significantly better for patients with Tis carcinomas (85.3% at 5 years) and patients with intramucosal T1 carcinomas (79.4%) than for patients with submucosal T1 carcinomas (16.3%) (p = 0.007 and p = 0.045, respectively). Survival at 5 years for the 49 patients without regional lymph node metastases (N0) was 65.2%, whereas none of the 5 patients with regional lymph node metastases (N1) have survived more than 3 years (p = 0.054), and 3 died of recurrent disease. There were 21 patients with SECD (13 T0, 2 Tis, and 6 T1). Survival at 4 years was 58.2%. In this group, survival was not related to depth of tumor invasion (p = 0.76) or regional lymph node status (p = 0.68).

Conclusions. We conclude that (1) patients with Tis and intramucosal T1 SECP have a significantly better survival than those with submucosal T1 SECP, (2) patients with N0 SECP have a significantly better survival than those with N1 SECP, and (3) survival of patients with SECD is not related to depth of tumor invasion or regional lymph node status.


Related Article

Discussion
Ann. Thorac. Surg. 1995 60: 902. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. Rampado, P. Bocus, G. Battaglia, A. Ruol, G. Portale, and E. Ancona
Endoscopic Ultrasound: Accuracy in Staging Superficial Carcinomas of the Esophagus
Ann. Thorac. Surg., January 1, 2008; 85(1): 251 - 256.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M S Dar, J R Goldblum, T W Rice, and G W Falk
Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?
Gut, April 1, 2003; 52(4): 486 - 489.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. A. Hagen and T. R. DeMeester
Esophageal adenocarcinoma
Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. J. Nigro, J. A. Hagen, T. R. DeMeester, S. R. DeMeester, J. H. Peters, S. Oberg, J. Theisen, M. Kiyabu, P. F. Crookes, and C. G. Bremner
PREVALENCE AND LOCATION OF NODAL METASTASES IN DISTAL ESOPHAGEAL ADENOCARCINOMA CONFINED TO THE WALL: IMPLICATIONS FOR THERAPY
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 16 - 25.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. W. Rice
COMMENTARY: ESOPHAGEAL CARCINOMA CONFINED TO THE WALL—THE NEED FOR IMMEDIATE DEFINITIVE THERAPY
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 26 - 27.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. W. Rice, G. Zuccaro Jr, D. J. Adelstein, L. A. Rybicki, E. H. Blackstone, and J. R. Goldblum
Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status
Ann. Thorac. Surg., March 1, 1998; 65(3): 787 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh
ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA
J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. A. Killinger Jr., T. W. Rice, D. J. Adelstein, S. V. Medendorp, G. Zuccaro, T. J. Kirby, and J. R. Goldblum
STAGE II ESOPHAGEAL CARCINOMA: THE SIGNIFICANCE OF T AND N
J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 935 - 940.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.